The leading location for therapeutic innovation
An ideal environment for growth within a supportive and networked community.
Scroll Down
World class capabilities in cell and gene technologies
Companies based on Campus employ over 4,000 people. We are home to major organisations including GSK, the Cell and Gene Therapy Manufacturing Catapult, LifeArc and Cytiva alongside a growing cluster of start-up companies which together have raised over £3.6bn in funding.
The Golden Triangle
SBC is located within the golden triangle and the academic centres of London, Cambridge and Oxford.
World Class Facilities
Our labs are fitted with the very latest technologies to ensure you have everything needed to succeed.
World class capabilities in cell and gene technologies
Companies based on Campus employ over 4,000 people. We are home to major organisations including GSK, the Cell and Gene Therapy Manufacturing Catapult, LifeArc and Cytiva alongside a growing cluster of start-up companies which together have raised over £3.6bn in funding.
The Golden Triangle
SBC is located within the golden triangle and the academic centres of London, Cambridge and Oxford.
World Class Facilities
Our labs are fitted with the very latest technologies to ensure you have everything needed to succeed.
Spaces for ventures of all sizes
The facilities have been designed to foster cooperation, scientific and commercial dialogue and interaction between entrepreneurs. Access is offered to business facilities that would otherwise be beyond the reach of small or medium-sized companies.
Spaces for ventures of all sizes
The facilities have been designed to foster cooperation, scientific and commercial dialogue and interaction between entrepreneurs. Access is offered to business support, equipment and facilities that would otherwise be beyond the reach of small or medium-sized companies.
The SBC team have been an invaluable source of support over the years, particularly during the pandemic and subsequent lockdown. Innovative SMEs in the UK bioscience space could not flourish without the right supportive infrastructure, something SBC have excelled at.
Prof. Mo Alavijeh FRSC FRSM
Managing Director
The SBC team have been instrumental, not just in infrastructure access but in fostering a network of founders and investors. If you’ve got an idea, and you’re looking for a place to be, come to Stevenage.
Pedro Correa de Sampaio PhD, Neobe Therapeutics
CEO and Co-founder
The ecosystem at SBC enabled us to spin out not one but two companies, secure > £60m from global investors and attract the talent we need to progress our much-needed therapies for chronic conditions.
Dr Mary Kerr, NeRRe Therapeutics
CEO
The SBC team have been an invaluable source of support over the years, particularly during the pandemic and subsequent lockdown. Innovative SMEs in the UK bioscience space could not flourish without the right supportive infrastructure, something SBC have excelled at.
Prof. Mo Alavijeh FRSC FRSM
Managing Director
The SBC team have been instrumental, not just in infrastructure access but in fostering a network of founders and investors. If you’ve got an idea, and you’re looking for a place to be, come to Stevenage.
Pedro Correa de Sampaio PhD, Neobe Therapeutics
CEO and Co-founder
The ecosystem at SBC enabled us to spin out not one but two companies, secure > £60m from global investors and attract the talent we need to progress our much-needed therapies for chronic conditions.
Dr Mary Kerr, NeRRe Therapeutics
CEO
Campus Occupiers
